Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Altis Biosystems logo — Capturing the Complexity of the Human Gut

Altis Biosystems

Capturing the Complexity of the Human Gut

Founded 2015 United States Durham, United States 28 employees Series A Biotechnology, Health Care +1

General Information

Company Name Altis Biosystems
Founded Year 2015
Location United States Durham, United States
Employees 28
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Altis Biosystems. To contact Altis Biosystems, visit altisbiosystems.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Altis Biosystems compare?

A PDF of Altis Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Altis Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Altis Biosystems

Altis Biosystems is a biotechnology startup that is dedicated to "Capturing the Complexity of the Human Gut." Founded in 2015 and headquartered in the United States, Altis Biosystems aims to provide scientific innovation through collaborative relationships to help companies develop safer and more effective therapies for patients suffering from human diseases. The company's flagship product is the Repligut® Systems, which are in vitro models derived from stem cells and specifically designed for pre-clinical drug discovery. These innovative systems overcome the limitations of conventional cell lines and animal models, providing a highly accurate representation of human intestinal physiology. Altis Biosystems' RepliGut® Planar models utilize human donor intestinal stem cells to advance novel pharmaceuticals through a process of sequential proliferation and differentiation, ultimately transforming into essential cell types found in the human gastrointestinal epithelium for use in drug discovery and development. Their RepliGut® Models, accurately replicating the complex cellular lifecycle of the intestinal crypt, offer a versatile platform for various applications including compound screening, disease modeling, drug disposition analysis, toxicity assessments, efficacy studies, and fundamental research investigations. The company's last investment was a Series A round on 09 January 2024, led by the Triangle Tweener Fund. Altis Biosystems' pioneering approach not only furthers the understanding of human biology but also has the potential to significantly reduce the dependence on animal studies in the pre-clinical drug discovery landscape.

Business keywords: Stem Cell Technology, Drug Discovery, Human Intestinal Epithelium, Compound Screening, Microbiome Research, Disease Modeling, Precision Medicine, Pharma Industry, Biotech Industry, Toxicology, Innovation, Research Tools, ADME, Inflammation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Triangle Tweener Fund
Triangle Tweener Fund
09 Jan 2024

Altis Biosystems Alternatives & Competitors

View All Alternatives
Altis Biosystems vs
StemoniX
StemoniX United States

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

Convertible Note
1 employees
Biotechnology, Health Care
Altis Biosystems vs
CN Bio
CN Bio United Kingdom

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.

Series B
59 employees
Biopharma, Biotechnology
Compare Altis Biosystems vs CN Bio
Altis Biosystems vs
pixlbio
pixlbio Sweden

pixl x bio: from cells to pixels to predictions

Series A
21 employees
Biotechnology, Health Care
Also compare with: Altis Biosystems vs Carcinotech Ltd Carcinotech Ltd View all alternatives

FAQ About Altis Biosystems

Capturing the Complexity of the Human Gut
Altis Biosystems was founded in 2015.
Altis Biosystems is headquartered in Durham, United States.
Altis Biosystems operates in Biotechnology, Health Care and Life Sciences. Its work centres on Stem Cell Technology, Drug Discovery, Human Intestinal Epithelium and Compound Screening.
Altis Biosystems has approximately 28 employees.
Altis Biosystems has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to Altis Biosystems include StemoniX, CN Bio, pixlbio, Carcinotech Ltd, NeuCyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Altis Biosystems and StemoniX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Altis Biosystems, https://bouncewatch.com/company/altis-biosystems, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes